Standout Papers
- The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions (2020)
- Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial (2016)
Immediate Impact
69 standout
Citing Papers
Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder
2024 Standout
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
2024 Standout
Works of Kaspar Broch being referenced
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
2020 Standout
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kaspar Broch | 836 | 352 | 714 | 430 | 84 | 1.9k | |
| Constantinos Bakogiannis | 1059 | 512 | 434 | 366 | 80 | 2.2k | |
| Matthew C. Hyman | 1006 | 321 | 552 | 552 | 69 | 2.6k | |
| Leo F. Buckley | 1170 | 511 | 616 | 251 | 90 | 2.3k | |
| Panagiotis Theofilis | 985 | 450 | 557 | 300 | 192 | 2.3k | |
| Dimitrios Stakos | 812 | 282 | 436 | 622 | 76 | 2.1k | |
| Mitsushige Nishikawa | 730 | 379 | 890 | 301 | 158 | 3.1k | |
| Daoquan Peng | 562 | 643 | 577 | 270 | 101 | 2.1k | |
| Kevin Shrestha | 1515 | 320 | 467 | 232 | 52 | 2.6k | |
| Amparo Galán | 895 | 350 | 508 | 506 | 69 | 2.1k | |
| Dorothee Atzler | 812 | 164 | 407 | 268 | 72 | 2.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...